B. Abderrahman

发表

Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women’s Health

V. Jordan, V. Jordan, B. Abderrahman, 2018, Endocrinology.

A Novel Strategy to Improve Women’s Health: Selective Estrogen Receptor Modulators

V. Jordan, V. Jordan, B. Abderrahman, 2018, Estrogen Receptor and Breast Cancer.

V. Jordan, B. Abderrahman, 2018 .

Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer

G. Greene, V. Jordan, S. Fanning, 2018, Molecular Pharmacology.

Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?

Poulomi Bhattacharya, V. Jordan, B. Abderrahman, 2017, Expert review of anticancer therapy.

The modulation of estrogen-induced apoptosis as an interpretation of the women’s health initiative trials

V. Jordan, B. Abderrahman, Craig Jordan, 2016, Expert review of endocrinology & metabolism.

The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy

V. Jordan, B. Abderrahman, P. Maximov, 2015, Molecular and Cellular Endocrinology.

Investigating Knowledge and Attitudes of Blood Donors and Barriers Concerning Blood Donation in Jordan

B. Abderrahman, M. Saleh, 2014 .

Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer

A. Malovannaya, C. Foulds, V. Jordan, 2020, Molecular Cancer Therapeutics.

Estrogen for the Treatment and Prevention of Breast Cancer

V. Jordan, B. Abderrahman, 2022, Cancer journal.

To the Editor.

B. Abderrahman, 2017, Menopause.

Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells

V. Jordan, B. Abderrahman, P. Fan, 2018, Molecular Cancer Therapeutics.

Estrogen Deprivation Therapy in Ovarian Cancer: An Opportunity.

V. Jordan, B. Abderrahman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer

B. Broom, H. Brauch, V. Speirs, 2020, Exploration of targeted anti-tumor therapy.

Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer.

V. Jordan, B. Abderrahman, 2018, JAMA oncology.

Oral pure antiestrogens as a solution to acquired drug resistance to aromatase inhibitors

G. Hortobagyi, V. Jordan, B. Abderrahman, 2015 .

Long-term Adjuvant Tamoxifen Therapy and Decreases in Contralateral Breast Cancer.

V. Jordan, V. Jordan, B. Abderrahman, 2017, JAMA oncology.

Tamoxifen Decreases Mortality, but How?

Poulomi Bhattacharya, V. Jordan, B. Abderrahman, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells

D. Siwak, V. Jordan, B. Abderrahman, 2019, Molecular Cancer Therapeutics.

A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers

V. Jordan, V. Jordan, B. Abderrahman, 2017, Endocrine-related cancer.

The First Targeted Therapy to Treat Cancer: The Tamoxifen Tale

V. Jordan, V. Jordan, B. Abderrahman, 2018, Estrogen Receptor and Breast Cancer.

Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer

V. Jordan, B. Abderrahman, P. Maximov, 2022, Frontiers in Endocrinology.

Exhaled breath biopsy: a new cancer detection paradigm.

B. Abderrahman, 2019, Future oncology.

Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.

Ping Fan, Poulomi Bhattacharya, V. Jordan, 2016, Discovery medicine.

Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer

G. Thatcher, V. Jordan, B. Abderrahman, 2020, Molecular Pharmacology.

Telling details of breast-cancer recurrence

V. Jordan, B. Abderrahman, 2018, Nature.

Cancer chemoprevention at the crossroads

V. Jordan, B. Abderrahman, 2015 .

Moving Precision Oncology Forward Amid Myths and Misconceptions.

V. Jordan, B. Abderrahman, 2018, JAMA oncology.

The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells

A. Malovannaya, B. Broom, C. Foulds, 2020, Molecular Pharmacology.

Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer.

B. Broom, H. Brauch, V. Speirs, 2020, Exploration of targeted anti-tumor therapy.

A brief discussion of aspects in breast cancer research, science mentorship and the workplace culture today

B. Abderrahman, 2017 .

Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?

Poulomi Bhattacharya, B. Abderrahman, C. Jordan, 2017, Expert review of anticancer therapy.

Improving long-term adjuvant anti-oestrogenic therapy for breast cancer

V. Jordan, B. Abderrahman, 2016 .